These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

76 related items for PubMed ID: 1470295

  • 1. [Cyclosporine and idiopathic extramembranous glomerulopathy. Hypothesis, facts and questions in 1992].
    Rostoker G.
    Nephrologie; 1992; 13(5):207-13. PubMed ID: 1470295
    [Abstract] [Full Text] [Related]

  • 2. Induction and long-term treatment with cyclosporine in membranous nephropathy with the nephrotic syndrome.
    Alexopoulos E, Papagianni A, Tsamelashvili M, Leontsini M, Memmos D.
    Nephrol Dial Transplant; 2006 Nov; 21(11):3127-32. PubMed ID: 16968719
    [Abstract] [Full Text] [Related]

  • 3. Long-term cyclosporin A therapy for severe idiopathic membranous nephropathy.
    Rostoker G, Belghiti D, Ben Maadi A, Rémy P, Lang P, Weil B, Lagrue G.
    Nephron; 1993 Nov; 63(3):335-41. PubMed ID: 8446273
    [Abstract] [Full Text] [Related]

  • 4. [Treatment of idiopathic nephrotic syndrome with cyclosporin A].
    Ariceta Iraola G, Rodríguez Soriano J, Vallo Boado A, Quintela Pérez MJ, Oliveros Pérez R.
    An Esp Pediatr; 1997 Sep; 47(3):273-8. PubMed ID: 9499280
    [Abstract] [Full Text] [Related]

  • 5. Corticosteroids and ciclosporin A in idiopathic membranous nephropathy: higher remission rates of nephrotic syndrome and less adverse reactions than after traditional treatment with cytotoxic drugs.
    Goumenos DS, Katopodis KP, Passadakis P, Vardaki E, Liakopoulos V, Dafnis E, Stefanidis I, Vargemezis V, Vlachojannis JG, Siamopoulos KC.
    Am J Nephrol; 2007 Sep; 27(3):226-31. PubMed ID: 17389782
    [Abstract] [Full Text] [Related]

  • 6. [Long-term administration of cyclosporine A in patients with IgA nephropathy].
    Chábová V, Tesar V, Zabka J, Rychlík I, Merta M, Jirsa M, Stejskalová A, Stejskal J.
    Cas Lek Cesk; 1996 Dec 18; 135(24):803-6. PubMed ID: 9072300
    [Abstract] [Full Text] [Related]

  • 7. The efficacy of cyclosporine A in adult nephrotic syndrome with minimal change disease and focal-segmental glomerulosclerosis: a multicenter study in Korea.
    Lee HY, Kim HS, Kang CM, Kim SG, Kim MJ.
    Clin Nephrol; 1995 Jun 18; 43(6):375-81. PubMed ID: 7554521
    [Abstract] [Full Text] [Related]

  • 8. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
    El-Husseini A, El-Basuony F, Mahmoud I, Sheashaa H, Sabry A, Hassan R, Taha N, Hassan N, Sayed-Ahmad N, Sobh M.
    Nephrol Dial Transplant; 2005 Nov 18; 20(11):2433-8. PubMed ID: 16204303
    [Abstract] [Full Text] [Related]

  • 9. Cyclosporine experience in nephrotic syndrome.
    Phadke K, Ballal S, Maiya V.
    Indian Pediatr; 1998 Feb 18; 35(2):111-6. PubMed ID: 9707852
    [Abstract] [Full Text] [Related]

  • 10. Cyclosporin A treatment for idiopathic membranous nephropathy.
    Yao X, Chen H, Wang Q, Tang Z, Hu W, Yin G, Liu Z, Li L.
    Chin Med J (Engl); 2001 Dec 18; 114(12):1305-8. PubMed ID: 11793859
    [Abstract] [Full Text] [Related]

  • 11. Cyclosporin A plus prednisone treatment of steroid-sensitive frequently relapsing nephrotic syndrome in children.
    Aksu N, Türker M, Erdoğan H, Ozinel S, Kansoy S.
    Turk J Pediatr; 1999 Dec 18; 41(2):225-30. PubMed ID: 10770662
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial.
    Choudhry S, Bagga A, Hari P, Sharma S, Kalaivani M, Dinda A.
    Am J Kidney Dis; 2009 May 18; 53(5):760-9. PubMed ID: 19268410
    [Abstract] [Full Text] [Related]

  • 13. [Cyclosporine in the treatment of glomerular diseases in children].
    Peco-Antić A, Popović-Rolović M, Jovanović O, Kostić M, Popović D.
    Srp Arh Celok Lek; 1992 May 18; 120(3-4):132-6. PubMed ID: 1465661
    [Abstract] [Full Text] [Related]

  • 14. Treatment of corticoresistant idiopathic nephrotic syndrome in the adult: minimal change disease and focal segmental glomerulosclerosis.
    Meyrier A, Simon P.
    Adv Nephrol Necker Hosp; 1988 May 18; 17():127-50. PubMed ID: 3124536
    [Abstract] [Full Text] [Related]

  • 15. Renal morphology after cyclosporin A therapy in rheumatoid arthritis patients. International Kidney Biopsy Registry of Cyclosporin (Sandimmun) in Autoimmune Diseases.
    Br J Rheumatol; 1993 Mar 18; 32 Suppl 1():65-71. PubMed ID: 8448642
    [Abstract] [Full Text] [Related]

  • 16. Patients with adult minimal change nephrotic syndrome treated with long-term cyclosporine did not experience a reduction in their eGFR.
    Inoue M, Yumura W, Morishita Y, Ito C, Hamano Y, Ando Y, Muto S, Kusano E.
    Clin Nephrol; 2013 Feb 18; 79(2):101-6. PubMed ID: 22948120
    [Abstract] [Full Text] [Related]

  • 17. [The treatment of nephrotic-type chronic glomerulonephritis with Sandimmun (cyclosporin A)].
    Mukhin NA, Tareeva IE, Krasnova TN, Shilov EM, Miroshnichenko NG.
    Ter Arkh; 1995 Feb 18; 67(8):13-5. PubMed ID: 7482320
    [Abstract] [Full Text] [Related]

  • 18. Cyclosporine in steroid dependent and resistant childhood nephrotic syndrome.
    Iyengar A, Karthik S, Kumar A, Biswas S, Phadke K.
    Indian Pediatr; 2006 Jan 18; 43(1):14-9. PubMed ID: 16465001
    [Abstract] [Full Text] [Related]

  • 19. Treatment of idiopathic nephrotic syndrome with cyclosporine A.
    Meyrier A.
    J Nephrol; 1997 Jan 18; 10(1):14-24. PubMed ID: 9241620
    [Abstract] [Full Text] [Related]

  • 20. Long-term benefits and risks of cyclosporin A (sandimmun)--an analysis at 10 years.
    Thiel G, Bock A, Spöndlin M, Brunner FP, Mihatsch M, Rufli T, Landmann J.
    Transplant Proc; 1994 Oct 18; 26(5):2493-8. PubMed ID: 7940765
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.